1. Ciuffoli, Veronica, Feng, Xuesong, Jiang, Kan, Dell'Orso, Stefania, Sartorelli, Vittorio. 2024. Psat1-generated α-ketoglutarate and glutamine promote muscle stem cell activation and regeneration. In Genes & development, 38, 151-167. doi:10.1101/gad.351428.123. https://pubmed.ncbi.nlm.nih.gov/38453480/
2. Jiang, Jingwen, Chen, Hai-Ning, Jin, Ping, Yu, Qiang, Huang, Canhua. 2023. Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant. In Signal transduction and targeted therapy, 8, 65. doi:10.1038/s41392-022-01266-7. https://pubmed.ncbi.nlm.nih.gov/36788227/
3. Roshanian Bakhsh, Mehdi, Peymani, Maryam, Rouhi, Leila, Ghaedi, Kamran. 2022. PSAT1 gene as a biomarker for targeting triple negative breast cancer in presence of Rapamycin. In Nucleosides, nucleotides & nucleic acids, 41, 166-182. doi:10.1080/15257770.2021.2025393. https://pubmed.ncbi.nlm.nih.gov/35038970/
4. Huang, Shang-Pen, Chan, Yung-Chieh, Huang, Shang-Yu, Lin, Yuan-Feng. 2019. Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion. In Cancers, 12, . doi:10.3390/cancers12010013. https://pubmed.ncbi.nlm.nih.gov/31861486/
5. Feng, Mingtao, Cui, Huanhuan, Tu, Wenjing, Zhou, Changshuai, Cao, Yiqun. 2022. An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy. In Frontiers in genetics, 13, 975381. doi:10.3389/fgene.2022.975381. https://pubmed.ncbi.nlm.nih.gov/36105075/
6. Liao, Kuang-Ming, Chao, Tung-Bo, Tian, Yu-Feng, Sheu, Ming-Jen, Li, Chien-Feng. 2016. Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis. In Journal of Cancer, 7, 1088-94. doi:10.7150/jca.15258. https://pubmed.ncbi.nlm.nih.gov/27326252/
智鼠故事 
